New York State Common Retirement Fund
SMMT icon

New York State Common Retirement Fund’s Summit Therapeutics SMMT Stock Holding History

New York State Common Retirement Fund’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$784K Hold
53,777
– – ﹤0.01% 1833
2026
Q1 		$1.02M Hold
53,777
– – ﹤0.01% 1656
2025
Q4 		$941K Sell
53,777
-210,513
-80% -$3.96M ﹤0.01% 1734
2025
Q3 		$5.46M Buy
264,290
+7,400
+3% +$179K 0.01% 1026
2025
Q2 		$5.47M Buy
256,890
+227,513
+774% +$5.19M 0.01% 1033
2025
Q1 		$567K Hold
29,377
– – ﹤0.01% 1851
2024
Q4 		$524K Buy
29,377
+4,600
+19% +$89.2K ﹤0.01% 1925
2024
Q3 		$543K Sell
24,777
-10,800
-30% -$151K ﹤0.01% 1913
2024
Q2 		$278K Sell
35,577
-12,748
-26% -$68.9K ﹤0.01% 2283
2024
Q1 		$200K Sell
48,325
-119
-0.2% -$473 ﹤0.01% 2443
2023
Q4 		$126K Sell
48,444
-215
-0.4% -$442 ﹤0.01% 2652
2023
Q3 		$91K Buy
48,659
+1,259
+3% +$2.4K ﹤0.01% 2775
2023
Q2 		$119K Buy
+47,400
New +$86.5K ﹤0.01% 2711
2022
Q3 		– Sell
-217
Closed – – 3429
2022
Q2 		$0 Sell
217
-14,600
-99% -$20.5K ﹤0.01% 3533
2022
Q1 		$36K Hold
14,817
– – ﹤0.01% 3229
2021
Q4 		$40K Sell
14,817
-11
-0.1% -$53 ﹤0.01% 3258
2021
Q3 		$74K Sell
14,828
-4,372
-23% -$31.4K ﹤0.01% 3198
2021
Q2 		$143K Buy
+19,200
New +$126K ﹤0.01% 3143

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

New York State Common Retirement Fund's SMMT Position: Q2 2026 in Review

New York State Common Retirement Fund held its Summit Therapeutics (SMMT) position steady in Q2 2026 at 53,777 shares worth $784K. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

New York State Common Retirement Fund first reported a position in SMMT in Q2 2021 and has held it in 18 quarters since. The position peaked at $5.47M in Q2 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • New York State Common Retirement Fund held 53,777 shares of Summit Therapeutics worth $784K as of Q2 2026.
  • New York State Common Retirement Fund left its Summit Therapeutics share count unchanged in Q2 2026.
  • Summit Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #1833 holding.
  • New York State Common Retirement Fund first reported a position in Summit Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Summit Therapeutics position peaked at $5.47M in Q2 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.